<DOC>
	<DOCNO>NCT00661219</DOCNO>
	<brief_summary>The study last three month . During first month treatment subject receive either 10 mg vardenafil placebo . After 1 month treatment doctor , choose increase dosage 10 mg 20 mg decrease dosage 5 mg . The doctor evaluate , 2 month treatment subject want increase dosage 10 mg 20 mg , already do , continue dosage 20 mg decrease 10 mg 5 mg . It possible point increase decrease dosage rest study . The subject ask attend clinic four separate occasion period 3 month . Every visit last 1 hour . At first visit doctor ask subject medical history , subject give medical examination ( include heart rate , blood pressure weight ) . The medical examination also include ECG . The subject ask provide blood urine sample , analyse screen drug potential abuse ( e.g.cocaine , narcotic , sedative , hypnotic ) . The subject ask fill questionnaire mood feeling . The subject qualifies , interview train mental health care provider ass level depression . At end visit , doctor provide subject diary must record detail attempt sexual activity next 4 week . The subject ask make least 4 attempt sexual intercourse 4 separate day record attempt diary . After 4 week subject return clinic . They ask fill different questionnaire sexuality , mood feeling , general quality life , self-esteem sexual activity last 4 week . Two additional blood urine sample collect . An interview train mental health care provider re-assess level depression . At visit information collect far assessed doctor check see requirement enter treatment period fulfil . The subject may exclude participation study , example due result blood analysis level depression meet criterion study . If subject able participate study give study drug . At visit , adverse event discuss whether change medicine . Vital sign ECG obtain visit one , two , five and/or Premature Termination . At every visit subject receive diary must record detail attempt sexual activity period visit number tablet take . Subjects also ask fill different questionnaire sexuality , mood feeling , self-esteem sexual activity . Subjects also contact telephone , 2 , 6 10 week start study medication , 24 hour last dose study medication . The doctor give study drug 3 occasion . Should subject doctor prematurely stop trial participation subject require return clinic physical examination , vital sign blood sample ECG obtain . They also ask fill different questionnaire .</brief_summary>
	<brief_title>Depression Related Improvement With Vardenafil Erectile Response</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Erectile dysfunction 6 month accord NIH Consensus statement ( inability attain maintain erection penis sufficient permit satisfactory sexual intercourse ) . Stable , heterosexual relationship 6 month . Diagnosis mild Major Depressive Disorder use structure interview ( SCID1 MINI ) , accord DSMIV criterion . Before randomization , psychiatrist must interview subject Visit 2 validate diagnosis MDD subject 's continuation study without need antidepressant medication psychotherapy ) . Patients must score great 13 CESD Visit 1 . Patients must score 11 17 17item HAMD Visit 1 Visit 2 . The patient must make least four attempt sexual intercourse four separate day untreated baseline period At least 50 % attempt sexual intercourse untreated baseline period unsuccessful Previous Current Medical Conditions Any unstable medical condition substance abuse disorder , opinion Investigator , likely affect patient 's ability complete study preclude patient 's participation study . Patients score &gt; 0 item # 3 HAMD17 men , investigator 's judgement , pose current serious suicidal homicidal risk make suicide attempt within past 12 month . Men current ( within 6 month prior screen ) Axis 1 disorder MDD ( major depressive disorder ) . Patients history , currently meet DSMIV criterion , Bipolar Disorder , Schizophrenia , Schizoaffective Disorder , Delusional ( Paranoid ) Disorder , Panic Disorder , PostTraumatic Stress Disorder . Patients Personality Disorder exclude , investigator 's opinion , interfere conduct trial . Retinitis pigmentosa . Unstable angina pectoris . History radical prostatectomy . History myocardial infarction , stroke , electrocardiographic ischemia ( except stable angina ) , lifethreatening arrhythmia within prior 6 month . Abnormal Laboratory Values AST ALT &gt; 3 time upper limit normal Concomitant Medications Patients take nitrate nitric oxide donor ( e.g. , molsidomine , minoxidil ) . Topical minoxidil permit . Patients take androgen ( e.g. , testosterone ) antiandrogens . Patients take trazodone , antidepressant include monoamine oxidase inhibitor , St. John 's Wort , SSRIs tricyclic antidepressant exclude , use medication last 2 week Visit 1 . Fluoxetine exclude last 4 week Visit 1 . Patients take follow potent inhibitor cytochrome P 450 3A4 : HIV protease inhibitor ritonavir indinavir , erythromycin antimycotic agent itraconazole ketoconazole ( topical form allow ) . Subjects take alphablockers . Use therapy erectile dysfunction within seven day Visit 1 trial . Patients require , likely require , treatment psychotherapy psychotropic drug course study . Men receive formal individual psychotherapy depression currently 12 week prior screen visit . Abnormal Laboratory Values Patients serum total testosterone level &gt; 10 % low limit normal ( accord range specify responsible laboratory ) . Other Exclusions Patients whose urine screen substance abuse positive . Patients unwilling refrain consume grapefruit juice product contain grapefruit juice study medication .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>